However, regardless of treatment schedule (treatment on days 0 to 5 or days 8 to 13 after induction of chronic GVHD), IL-18 treatment generated anti-host CTLs, but did not induce acute GVHD [14]. Here, IL18 is linked to acute graft versus host disease.